Holen Sie sich die Stockscreener-App
0.46
1.55%
0.007
Schlusskurs vom Vortag:
$0.453
Offen:
$0.4506
24-Stunden-Volumen:
164.57K
Relative Volume:
0.18
Marktkapitalisierung:
$24.28M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-24.08M
KGV:
-0.5366
EPS:
-0.8572
Netto-Cashflow:
$-14.75M
1W Leistung:
+10.26%
1M Leistung:
-23.15%
6M Leistung:
-55.77%
1J Leistung:
-80.00%
1-Tages-Spanne:
$0.45
$0.4732
1-Wochen-Bereich:
$0.4105
$0.5486
52-Wochen-Spanne:
$0.3622
$2.27
Iterum Therapeutics Plc Stock (ITRM) Company Profile
Firmenname
Iterum Therapeutics Plc
Sektor
Branche
Telefon
(872) 225-6077
Adresse
3 DUBLIN LANDINGS, DUBLIN 1
Vergleichen Sie ITRM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ITRM
Iterum Therapeutics Plc
|
0.46 | 23.91M | 0 | -24.08M | -14.75M | -0.8572 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Iterum Therapeutics Plc Stock (ITRM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-05-28 | Hochstufung | Gabelli & Co | Sell → Hold |
| 2021-03-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-06-02 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-01-21 | Herabstufung | Gabelli & Co | Buy → Sell |
| 2019-12-11 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-06-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Iterum Therapeutics Plc Aktie (ITRM) Neueste Nachrichten
Iterum Therapeutics Plc (ITRM) can make a big difference with a little luck - Setenews
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH By Investing.com - Investing.com Nigeria
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH - Investing.com
ITRM Expands ORLYNVAH Access and Secures Key Medicare Part D Agr - GuruFocus
Iterum Therapeutics provides business update - marketscreener.com
Iterum Therapeutics Provides Business Update - The Manila Times
Iterum Therapeutics (Nasdaq: ITRM) inks Medicare Part D deal, EU patent to 2039 - Stock Titan
Iterum Therapeutics (ITRM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Taking on analysts’ expectations and winning: Iterum Therapeutics Plc (ITRM) - Setenews
Iterum Therapeutics Plc (ITRM) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Iterum’s antibiotic ORLYNVAH now available through McKesson By Investing.com - Investing.com Nigeria
Iterum’s antibiotic ORLYNVAH now available through McKesson - Investing.com
Iterum Therapeutics (ITRM) Expands Product Availability and FDA Clearance - GuruFocus
Iterum (NASDAQ: ITRM) Adds McKesson for ORLYNVAH as Sulopenem Disc Gains FDA 510(k) - Stock Titan
Q3 2025 Iterum Therapeutics PLC Earnings Call Transcript - GuruFocus
Is Iterum Therapeutics plc stock attractive after correctionPortfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Why retail investors favor Iterum Therapeutics plc stockJuly 2025 Sentiment & Accurate Technical Buy Alerts - newser.com
Can Iterum Therapeutics plc stock maintain operating marginsJuly 2025 Weekly Recap & Trade Opportunity Analysis - newser.com
Iterum Therapeutics director Dunne buys $2,191 in shares By Investing.com - Investing.com Nigeria
Dir Dunne Buys 6,000 ($2.2K) Of Iterum Therapeutics PLC [ITRM] - TradingView
[Form 4] Iterum Therapeutics plc Insider Trading Activity - Stock Titan
Can Iterum Therapeutics plc stock resist market sell offs2025 Big Picture & Fast Gain Swing Alerts - newser.com
Why Iterum Therapeutics plc stock appeals to analysts2025 Technical Overview & High Accuracy Trade Alerts - newser.com
Combining machine learning predictions for Iterum Therapeutics plc2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Published on: 2025-11-19 01:58:59 - newser.com
Is Iterum Therapeutics plc stock attractive for long term wealth buildingQuarterly Market Review & Risk Managed Investment Strategies - newser.com
Using portfolio simulators with Iterum Therapeutics plc includedMarket Trend Report & Reliable Entry Point Alerts - newser.com
There is no way Iterum Therapeutics Plc (ITRM) can keep these numbers up - Setenews
Finanzdaten der Iterum Therapeutics Plc-Aktie (ITRM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):